Van Berkom & Associates Inc. Charles River Laboratories International, Inc. Transaction History

Van Berkom & Associates Inc.

  • $3.11 Billion
  • Q1 2025

A detailed history of Van Berkom & Associates Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Van Berkom & Associates Inc. holds 447,086 shares of CRL stock, worth $84.2 Million. This represents 2.16% of its overall portfolio holdings.

Number of Shares
447,086
Previous 387,998 15.23%
Holding current value
$84.2 Million
Previous $71.6 Million 6.04%
% of portfolio
2.16%
Previous 2.13%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 07, 2025
BUY
$150.52 - $190.14 $8.89 Million - $11.2 Million
59,088 Added 15.23%
447,086 $67.3 Million
Q4 2024

Feb 03, 2025
SELL
$178.58 - $220.69 $327,872 - $405,186
-1,836 Reduced 0.47%
387,998 $71.6 Million
Q3 2024

Nov 04, 2024
BUY
$187.96 - $245.29 $13.5 Million - $17.6 Million
71,606 Added 22.5%
389,834 $76.8 Million
Q2 2024

Aug 07, 2024
BUY
$206.39 - $268.73 $1.4 Million - $1.82 Million
6,762 Added 2.17%
318,228 $65.7 Million
Q1 2024

May 13, 2024
SELL
$203.52 - $273.43 $1.41 Million - $1.9 Million
-6,947 Reduced 2.18%
311,466 $84.4 Million
Q4 2023

Feb 06, 2024
BUY
$164.52 - $238.84 $15.8 Million - $23 Million
96,215 Added 43.3%
318,413 $75.3 Million
Q3 2023

Nov 07, 2023
BUY
$194.44 - $217.61 $6.53 Million - $7.31 Million
33,570 Added 17.8%
222,198 $43.5 Million
Q2 2023

Aug 07, 2023
SELL
$183.71 - $210.25 $436,678 - $499,764
-2,377 Reduced 1.24%
188,628 $39.7 Million
Q1 2023

May 10, 2023
BUY
$191.89 - $259.92 $2.1 Million - $2.85 Million
10,955 Added 6.08%
191,005 $38.5 Million
Q4 2022

Feb 13, 2023
BUY
$197.11 - $250.07 $1,773 - $2,250
9 Added 0.0%
180,050 $39.2 Million
Q3 2022

Nov 14, 2022
SELL
$182.44 - $250.54 $3.45 Million - $4.74 Million
-18,905 Reduced 9.5%
180,041 $35.4 Million
Q2 2022

Jul 22, 2022
SELL
$204.13 - $302.4 $494,198 - $732,110
-2,421 Reduced 1.2%
198,946 $42.6 Million
Q1 2022

May 11, 2022
SELL
$255.51 - $362.11 $5.25 Million - $7.44 Million
-20,553 Reduced 9.26%
201,367 $57.2 Million
Q4 2021

Feb 02, 2022
SELL
$351.38 - $448.68 $2.03 Million - $2.59 Million
-5,765 Reduced 2.53%
221,920 $83.6 Million
Q3 2021

Nov 12, 2021
SELL
$372.64 - $458.3 $42.7 Million - $52.5 Million
-114,641 Reduced 33.49%
227,685 $94 Million
Q2 2021

Aug 12, 2021
SELL
$294.17 - $371.65 $48.3 Million - $61.1 Million
-164,338 Reduced 32.44%
342,326 $127 Million
Q1 2021

May 14, 2021
SELL
$249.67 - $299.48 $8.35 Million - $10 Million
-33,463 Reduced 6.2%
506,664 $147 Million
Q4 2020

Feb 05, 2021
SELL
$222.0 - $252.62 $807,414 - $918,778
-3,637 Reduced 0.67%
540,127 $135 Million
Q3 2020

Nov 12, 2020
SELL
$175.56 - $226.45 $21.1 Million - $27.2 Million
-120,091 Reduced 18.09%
543,764 $123 Million
Q2 2020

Aug 12, 2020
SELL
$118.84 - $189.72 $4.75 Million - $7.58 Million
-39,945 Reduced 5.68%
663,855 $116 Million
Q1 2020

May 26, 2020
BUY
$98.9 - $178.34 $11.9 Million - $21.4 Million
119,919 Added 20.54%
703,800 $88.8 Million
Q4 2019

Feb 13, 2020
BUY
$126.05 - $152.76 $118,360 - $143,441
939 Added 0.16%
583,881 $89.2 Million
Q3 2019

Nov 13, 2019
BUY
$125.07 - $143.67 $1.08 Million - $1.24 Million
8,665 Added 1.51%
582,942 $77.2 Million
Q2 2019

Aug 13, 2019
SELL
$123.4 - $148.55 $184,483 - $222,082
-1,495 Reduced 0.26%
574,277 $81.5 Million
Q1 2019

May 14, 2019
SELL
$104.82 - $146.73 $867,804 - $1.21 Million
-8,279 Reduced 1.42%
575,772 $83.6 Million
Q4 2018

Feb 13, 2019
SELL
$105.09 - $137.23 $2.12 Million - $2.77 Million
-20,204 Reduced 3.34%
584,051 $66.1 Million
Q3 2018

Nov 08, 2018
SELL
$112.11 - $134.54 $1.47 Million - $1.77 Million
-13,136 Reduced 2.13%
604,255 $81.3 Million
Q2 2018

Aug 09, 2018
BUY
$102.37 - $117.25 $435,072 - $498,312
4,250 Added 0.69%
617,391 $69.3 Million
Q1 2018

May 08, 2018
BUY
$98.19 - $115.2 $2.31 Million - $2.71 Million
23,504 Added 3.99%
613,141 $65.4 Million
Q4 2017

Feb 13, 2018
SELL
$100.43 - $118.09 $6.25 Million - $7.35 Million
-62,216 Reduced 9.54%
589,637 $64.5 Million
Q3 2017

Nov 09, 2017
BUY
$96.72 - $109.26 $63 Million - $71.2 Million
651,853
651,853 $70.4 Million

Others Institutions Holding CRL

# of Institutions
622
Shares Held
52.5M
Call Options Held
1.42M
Put Options Held
1.42M
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.58B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Van Berkom & Associates Inc. Portfolio

Follow Van Berkom & Associates Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Berkom & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Van Berkom & Associates Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email